Treatment planning technique in patients receiving postmastectomy radiation therapy

Practical Radiation Oncology

Volumn 3, Issue 4, 2013, Pages 241-248

  Blitzblau, Rachel C ^a   Horton, Janet K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL ORGANS, TISSUES AND CELLS; BOLUS MATERIAL; BREAST CANCER; BREATH HOLDING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DEEP INSPIRATORY BREATH HOLD; DISEASE ASSOCIATION; DOSE VOLUME HISTOGRAM; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MASTECTOMY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION DOSE REDUCTION; RADIATION HAZARD; RADIATION ONCOLOGIST; RADIATION PNEUMONIA; RADIATION RESPONSE; RADIATION SHIELD; RADIOLOGICAL PARAMETERS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

EID: 84884352107     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2012.09.004     Document Type: Review

References (50)

1. Nielsen H.M., Overgaard M., Grau C., Jensen A.R., Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006, 24:2268-2275.
2. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005, 97:116-126.
3. Recht A. Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy. Semin Radiat Oncol 1999, 9:223-229.
4. Taghian A., Jeong J.H., Mamounas E., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004, 22:4247-4254.
5. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19:1539-1569.
6. Allen A.M., Prosnitz R.G., Ten Haken R.K., et al. Body mass index predicts the incidence of radiation pneumonitis in breast cancer patients. Cancer J 2005, 11:390-398.
7. Blom Goldman U., Wennberg B., Svane G., Bylund H., Lind P. Reduction of radiation pneumonitis by V20-constraints in breast cancer. Radiat Oncol 2010, 5:99.
8. Lind P.A., Marks L.B., Hardenbergh P.H., et al. Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 2002, 52:137-143.
9. Lingos T.I., Recht A., Vicini F., Abner A., Silver B., Harris J.R. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991, 21:355-360.
10. Osako T., Oguchi M., Kumada M., Nemoto K., Iwase T., Yamashita T. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy. Jpn J Clin Oncol 2008, 38:334-338.
11. Lind P.A., Gagliardi G., Wennberg B., Fornander T. A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol 1997, 36:509-515.
12. Marks L.B., Bentzen S.M., Deasy J.O., et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S70-S76.
13. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323-329.
14. Erven K., Weltens C., Nackaerts K., Fieuws S., Decramer M., Lievens Y. Changes in pulmonary function up to 10 years after locoregional breast irradiation. Int J Radiat Oncol Biol Phys 2012, 82:701-707.
15. Kimsey F.C., Mendenhall N.P., Ewald L.M., Coons T.S., Layon A.J. Is radiation treatment volume a predictor for acute or late effect on pulmonary function? A prospective study of patients treated with breast-conserving surgery and postoperative irradiation. Cancer 1994, 73:2549-2555.
16. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994, 12:447-453.
17. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000, 355:1757-1770.
18. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
19. Darby S.C., McGale P., Taylor C.W., et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005, 6:557-565.
20. Giordano S.H., Kuo Y.F., Freeman J.L., Buchholz T.A., Hortobagyi G.N., Goodwin J.S. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005, 97:419-424.
21. Patt D.A., Goodwin J.S., Kuo Y.F., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 2005, 23:7475-7482.
22. McGale P., Darby S.C., Hall P., et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 2011, 100:167-170.
23. Prosnitz R.G., Hubbs J.L., Evans E.S., et al. Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment. Cancer 2007, 110:1840-1850.
24. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
25. Gagliardi G., Lax I., Ottolenghi A., Rutqvist L.E. Long-term cardiac mortality after radiotherapy of breast cancer-application of the relative seriality model. Br J Radiol 1996, 69:839-846.
26. Gagliardi G., Constine L.S., Moiseenko V., et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S77-S85.
27. Landau D., Adams E.J., Webb S., Ross G. Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol 2001, 60:247-255.
28. Jagsi R., Griffith K.A., Koelling T., Roberts R., Pierce L.J. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer 2007, 109:650-657.
29. Vikström J., Hjelstuen M.H., Mjaaland I., Dybvik K.I. Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol 2011, 50:42-50.
30. Korreman S.S., Pedersen A.N., Nøttrup T.J., Specht L., Nyström H. Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol 2005, 76:311-318.
31. Pierce L.J., Butler J.B., Martel M.K., et al. Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 2002, 52:1220-1230.
32. Korreman S.S., Pedersen A.N., Aarup L.R., Nøttrup T.J., Specht L., Nyström H. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2006, 65:1375-1380.
33. Hurkmans C.W., Cho B.C., Damen E., Zijp L., Mijnheer B.J. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 2002, 62:163-171.
34. Hsu S.H., Roberson P.L., Chen Y., Marsh R.B., Pierce L.J., Moran J.M. Assessment of skin dose for breast chest wall radiotherapy as a function of bolus material. Phys Med Biol 2008, 53:2593-2606.
35. Metz J.M., Schultz D.J., Fox K., Glick J., Solin L.J. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence. Cancer J Sci Am 1999, 5:77-83.
36. Uematsu M., Bornstein B.A., Recht A., et al. Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer. Int J Radiat Oncol Biol Phys 1993, 25:765-770.
37. Bristol I.J., Woodward W.A., Strom E.A., et al. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 2008, 72:474-484.
38. Damast S., Ho A.Y., Montgomery L., et al. Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era. Int J Radiat Oncol Biol Phys 2010, 77:1105-1112.
39. Cavey M.L., Bayouth J.E., Endres E.J., Pena J.M., Colman M., Hatch S. Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers. Med Dosim 2005, 30:107-116.
40. Koshy M., Zhang B., Naqvi S., Liu B., Mohiuddin M.M. A novel technique for post-mastectomy breast irradiation utilising non-coplanar intensity-modulated radiation therapy. Br J Radiol 2010, 83:874-881.
41. Krueger E.A., Fraass B.A., McShan D.L., Marsh R., Pierce L.J. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003, 56:1023-1037.
42. Pignol J.P., Olivotto I., Rakovitch E., et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26:2085-2092.
43. Smith B.D., Pan I.W., Shih Y.C., et al. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst 2011, 103:798-809.
44. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
45. Donegan W.L., Perez-Mesa C.M., Watson F.R. A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 1966, 122:529-540.
46. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999, 17:1689-1700.
47. Katz A., Strom E.A., Buchholz T.A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000, 18:2817-2827.
48. Katz A., Buchholz T.A., Thames H., et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys 2001, 50:397-403.
49. Jagsi R., Raad R.A., Goldberg S., et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 2005, 62:1035-1039.
50. Cheng S.H., Horng C.F., Clarke J.L., et al. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys 2006, 64:1401-1409.